Difference between revisions of "Li Y, et al, Sci Rep (2016), cited as Ref 22 in DOI: 10.1007/s11886-020-01293-2 (Q11016)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2016, #quickstatements; #temporary_batch_1592835264664) |
(Created claim: First Author string (P149): Li Y, #quickstatements; #temporary_batch_1592835264664) |
||
| Property / First Author string | |||
| + | Li Y | ||
| Property / First Author string: Li Y / rank | |||
| + | Normal rank | ||
Revision as of 14:16, 22 June 2020
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Li Y, et al, Sci Rep (2016), cited as Ref 22 in DOI: 10.1007/s11886-020-01293-2
|
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
|
Statements
Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-kappaB signaling pathways (English)
0 references
2016
0 references
Li Y
0 references
